PTCT Q2 2020 Earnings — PTC Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PTCTPTC Therapeutics, Inc.

$5B

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$75M-12.0% YoY

Gross Profit

$70M93.0% margin

Operating Income

-$187M-248.9% margin

Net Income

-$181M-241.1% margin

EPS (Diluted)

$-2.78

QoQ Revenue Growth

+10.2%

Cash Flow

Operating Cash Flow

-$75M

Free Cash Flow

-$77M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$904M

Stockholders' Equity

$572M

Cash & Equivalents

$158M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$75M	$86M	-12.0%
Gross Profit	$70M	$82M	-15.0%
Operating Income	-$187M	-$39M	-383.2%
Net Income	-$181M	-$42M	-334.2%

Revenue Segments

Product

$75M100%